| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.1M | -69.2% |
| SG&A Expense | $2.1M | -17.1% |
| Operating Income | -$4.2M | +55.3% |
| Net Income | -$4.1M | +54.0% |
| EPS (Basic) | -$4.83 | +85.8% |
| EPS (Diluted) | -$4.83 | +85.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $3.9M | +3.3% |
| Total Assets | $3.9M | +3.3% |
| Current Liabilities | $378K | -54.6% |
| Total Liabilities | $378K | -54.6% |
| Stockholders' Equity | $3.5M | +19.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.1M | +56.8% |
| Financing Cash Flow | $4.4M | -12.3% |